CRISPR Therapeutics AG (NASDAQ:CRSP) currently has a daily average trading volume of 1.08M but it saw 1826310 shares traded in last market. With a market cap of 3.92B USD, the company’s current market price of $46.00 came falling about -4.25 while comparing to the previous closing price of $48.04. In past 52 weeks, the stock remained buoying in the range of price level as high as $91.10 and as low as $37.55. In the recent trading on the day, stock has struck highest price mark of $45.44 while lowest mark touched by it was $47.96.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Needham which reiterated the stock as “Buy” in its note to investors issued on August 06, 2024, recommending a price target of between $88 and $84 for it.
Over the week, CRSP’s stock price is moving -6.12% down while it is -1.69% when we observe its performance for the past one month. Year-to-date it is -26.52% down and over the past year, the stock is showing an upside performance of 19.11%.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of -1.41 beat the consensus estimate of -1.95 for the same. The company is expected to be releasing its next quarterly report in November, for which analysts forecasted an EPS of -1.42 while estimate for next year EPS is -5.67. In next quarter, company is expected to be making quarterly sales of $31.88M as analysts are expecting the sales for current fiscal year at $48.79M and seeing the company making $279.98M in sales next year. Moreover, analysts are in estimates of $6.81M for current-quarter revenue.
Currently, CRISPR Therapeutics AG’s total number of outstanding shares is 85.17M. Company’s return on investment (ROI) stands at -12.11% and return on equity (ROE) at -14.00%. Stock’s beta reads 1.66. Stock has a price to book (P/B) ratio of 1.97 while price to sale or P/S ratio amounts to 19.37. Its return on asset (ROA) is -11.72% on average.
